Coherus Oncology Company Profile, Contacts & Intelligence
Coherus Oncology Overview
Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.
- Headquarters
- Redwood City, California, United States
- Website
- www.coherus.com
- Industry
- Biotechnology Research
- Founded
- 2010
- Stock Symbol
- ARQT
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Coherus Oncology Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Coherus Oncology People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Coherus Oncology Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to Coherus Oncology
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Jazz Pharmaceuticals | Pharmaceutical Manufacturing | 3.45K | View company |
| Exelixis | Biotechnology Research | 1.50K | View company |
| Ionis Pharmaceuticals, Inc. | Biotechnology Research | 1.27K | View company |
| Apellis Pharmaceuticals | Biotechnology Research | 783 | View company |
| BridgeBio | Biotechnology Research | 778 | View company |
| Agios Pharmaceuticals | Pharmaceutical Manufacturing | 654 | View company |
| Corcept Therapeutics | Biotechnology Research | 634 | View company |
| Cytokinetics | Biotechnology Research | 634 | View company |
| Crinetics Pharmaceuticals | Biotechnology Research | 510 | View company |
| Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) | Biotechnology Research | 378 | View company |